137 related articles for article (PubMed ID: 8846839)
21. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
22. The effects of ocular hypotensive doses of PGF2 alpha-isopropylester on anterior segment morphology.
Lütjen-Drecoll E; Tamm E
Prog Clin Biol Res; 1989; 312():437-46. PubMed ID: 2678149
[TBL] [Abstract][Full Text] [Related]
23. Effect of topical prostaglandin PGA2, PGA2 isopropyl ester, and PGF2 alpha isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes.
Gum GG; Kingsbury S; Whitley RD; Garcia A; Gelatt KN
J Ocul Pharmacol; 1991; 7(2):107-16. PubMed ID: 1919268
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey.
Gabelt BT; Kaufman PL
Exp Eye Res; 1989 Sep; 49(3):389-402. PubMed ID: 2792235
[TBL] [Abstract][Full Text] [Related]
25. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
Goh Y; Nakajima M; Azuma I; Hayaishi O
Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
[TBL] [Abstract][Full Text] [Related]
26. Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients.
Lee PY; Shao H; Camras CB; Podos SM
Ophthalmology; 1991 Jul; 98(7):1079-82. PubMed ID: 1891217
[TBL] [Abstract][Full Text] [Related]
27. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
[TBL] [Abstract][Full Text] [Related]
28. Effect of topical prostaglandin D2 on the aqueous humor dynamics in rabbits.
Goh Y; Araie M; Nakajima M; Azuma I; Hayaishi O
Graefes Arch Clin Exp Ophthalmol; 1989; 227(5):476-81. PubMed ID: 2478423
[TBL] [Abstract][Full Text] [Related]
29. Topical and intravenous pilocarpine stimulated accommodation in anesthetized rhesus monkeys.
Wendt M; Glasser A
Exp Eye Res; 2010 May; 90(5):605-16. PubMed ID: 20159011
[TBL] [Abstract][Full Text] [Related]
30. Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha.
Camras CB; Bito LZ
Curr Eye Res; 1981; 1(4):205-9. PubMed ID: 6949676
[TBL] [Abstract][Full Text] [Related]
31. Effects of pharmacologically manipulated amplitude and starting point on edinger-westphal-stimulated accommodative dynamics in rhesus monkeys.
Ostrin LA; Glasser A
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):313-20. PubMed ID: 17197548
[TBL] [Abstract][Full Text] [Related]
32. Anticholinesterase-induced cholinergic subsensitivity in primate accommodative mechanism.
Kaufman PL
Am J Ophthalmol; 1978 May; 85(5 Pt 1):622-31. PubMed ID: 418688
[TBL] [Abstract][Full Text] [Related]
33. Effect of low-dose latrunculin B on anterior segment physiologic features in the monkey eye.
Okka M; Tian B; Kaufman PL
Arch Ophthalmol; 2004 Oct; 122(10):1482-8. PubMed ID: 15477460
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes.
Stern FA; Bito LZ
Invest Ophthalmol Vis Sci; 1982 May; 22(5):588-98. PubMed ID: 7076404
[TBL] [Abstract][Full Text] [Related]
35. Pilocarpine-induced subsensitivity to carbachol and pilocarpine of ciliary muscle in vervet and cynomolgus monkeys.
Bárány EH
Acta Ophthalmol (Copenh); 1977 Feb; 55(1):141-63. PubMed ID: 402785
[TBL] [Abstract][Full Text] [Related]
36. Initial clinical studies with prostaglandins and their analogues.
Camras CB; Alm A
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S61-8. PubMed ID: 9154278
[TBL] [Abstract][Full Text] [Related]
37. Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes.
Lee PY; Podos SM; Serle JB; Camras CB; Severin CH
Arch Ophthalmol; 1987 Feb; 105(2):249-52. PubMed ID: 3813959
[TBL] [Abstract][Full Text] [Related]
38. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.
Bito LZ; Draga A; Blanco J; Camras CB
Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):312-9. PubMed ID: 6572617
[TBL] [Abstract][Full Text] [Related]
39. [The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals].
Ueno R; Yoshida S; Deguchi T; Kato I; Oda T; Hayashi Y; Kuno S
Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):462-8. PubMed ID: 1621584
[TBL] [Abstract][Full Text] [Related]
40. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure.
Woodward DF; Williams LS; Chen J
Ophthalmic Res; 1989; 21(6):428-35. PubMed ID: 2626239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
